Advanced Gut Repair Protocol
Four-compound gut restoration protocol combining Colostrum, BPC-157, KPV, and Sodium Butyrate with Zinc. Addresses intestinal barrier integrity, mucosal repair, and inflammatory suppression simultaneously.
Daily Schedule
Timing and dosage for each step
Morning
Morning
Morning
With meals
With meals
Protocol Overview
The gut barrier — a single cell layer separating the intestinal contents from systemic circulation — is increasingly recognised as a master regulator of systemic health. Barrier disruption ("leaky gut") allows bacterial endotoxins (LPS), food antigens, and microbial metabolites into circulation, driving chronic low-grade inflammation that contributes to metabolic disease, autoimmunity, cognitive decline, and accelerated ageing.
This protocol addresses gut barrier dysfunction through four synergistic mechanisms: structural repair (BPC-157), inflammatory suppression (KPV), epithelial energy supply and epigenetic modulation (Sodium Butyrate), and growth factor-mediated regeneration (Colostrum) — with Zinc as a cofactor.
The Four-Mechanism Approach
BPC-157 (Body Protection Compound) upregulates VEGF for angiogenesis, activates FAK-paxillin for directed fibroblast migration, and sensitises GH receptors at the mucosal surface. These mechanisms combine to accelerate mucosal structural repair.
KPV (Lys-Pro-Val, alpha-MSH C-terminal tripeptide) directly suppresses NF-κB in intestinal epithelial cells and macrophages, reducing the inflammatory cytokine cascade without immunosuppression. KPV's oral stability makes it uniquely suited for gut delivery without injection.
Sodium Butyrate is the primary energy substrate for colonocytes and a potent HDAC inhibitor. HDAC inhibition shifts gene expression toward anti-inflammatory, tight junction-upregulating patterns. Enteric-coated forms ensure colonic delivery.
Colostrum provides growth factors (IGF-1, EGF, TGF-β) that drive mucosal cell proliferation and tight junction protein expression. The immunoglobulin fraction (IgA) supports mucosal immunity without systemic immunosuppression.
Zinc is a cofactor for tight junction protein synthesis and directly upregulates occludin and ZO-1 expression. Zinc deficiency is common in gut-compromised individuals.
Dosing Protocol
| Compound | Dose | Timing | Route |
|---|---|---|---|
| BPC-157 | 250–500mcg/day | Morning, fasted | Oral capsule |
| KPV | 250–500mcg/day | Morning, fasted | Oral capsule |
| Colostrum | 2–4g/day | Morning with BPC-157 | Oral powder/capsule |
| Sodium Butyrate | 600mg/day | With meals | Oral, enteric-coated |
| Zinc | 15–30mg/day | With meals | Oral |
Loading phase: Full protocol 8–12 weeks. Maintenance: BPC-157 and Colostrum can be reduced to 3x/week; Sodium Butyrate and Zinc continue daily.
Indicators to Track
Subjective: bloating, stool consistency (Bristol scale), post-meal discomfort, energy levels. Objective: zonulin (leaky gut marker), hs-CRP, food sensitivity panel at 12 weeks.